Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cyclerion Therapeutics Inc CYCN

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company that focuses on developing treatments for serious diseases. The Company’s portfolio includes novel soluble guanylate cyclase (sGC) stimulators, namely praliciguat and olinciguat, as well as multiple research stage molecules. Praliciguat is a systemic sGC stimulator that is licensed to Akebia Therapeutics, Inc. for the treatment of rare kidney disease. Olinciguat is a vascular sGC stimulator that the Company intends to out-license for cardiovascular diseases. The Company operates through the human therapeutics segment. The Company is focused on identifying non-sGC stimulator assets within the central nervous system (CNS) therapeutic area to build a new portfolio. The Company is also evaluating other activities aimed at enhancing shareholder value, which potentially include collaborations, licenses, mergers, acquisitions and/or other targeted investments.


NDAQ:CYCN - Post by User

Post by AviseAnalyticson Nov 12, 2021 7:05am
119 Views
Post# 34118397

5 STOCKS FOR YOUR INVESTMENT WATCHLIST!

5 STOCKS FOR YOUR INVESTMENT WATCHLIST!

5 STOCKS FOR YOUR INVESTMENT WATCHLIST!

 

CYCN COGT QIPT CHS POLY

https://www.aviseanalytics.com/5-stocks-for-your-investment-watchlist/

 

Technology Industry has been focused on minimizing the impact of COVID-19 and marching ahead with its innovations and breakthroughs, be it critical security systems, innovative marketing solutions or cutting-edge data analytics and search technology.

 

We take a look at some tech companies that are impervious to the scare and offer a very attractive upside in the long run.

https://www.aviseanalytics.com/5-stocks-for-your-investment-watchlist/

Bullboard Posts
Next >>